Rating Change
HC Wainwright & Co. reiterated its Buy rating on UroGen Pharma Ltd. (NASDAQ:URGN) on October 19, 2026.
reiterateNASDAQ:URGN
HC Wainwright & Co. Reiterates Buy Rating on UroGen Pharma Ltd. (URGN)
HC Wainwright & Co. reiterated its Buy rating on UroGen Pharma Ltd.
At publication ·
What changed
UroGen Pharma Ltd. (NASDAQ:URGN) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $33.95
- Market capitalization
- $1.0B
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Buy rating on UroGen Pharma on October 19, 2026, with the stock trading at $33.95.
Market Context
UroGen Pharma Ltd. operates in the Healthcare sector. The stock currently trades at $33.95 with a market capitalization of $1.0B. The stock has gained 99.9% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for UroGen Pharma Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for UroGen Pharma Ltd.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 06, 2026 | Guggenheim | Buy | N/A |
| Aug 06, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 05, 2026 | TD Cowen | Buy | N/A |
| Jul 21, 2026 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View URGN Stock Page
Frequently Asked Questions
What does the Buy rating mean for URGN?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on UroGen Pharma Ltd. (NASDAQ:URGN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the URGN forecast page.
